Discover millions of ebooks, audiobooks, and so much more with a free trial

Only $11.99/month after trial. Cancel anytime.

The Organic Chemistry of Drug Design and Drug Action
The Organic Chemistry of Drug Design and Drug Action
The Organic Chemistry of Drug Design and Drug Action
Ebook1,232 pages

The Organic Chemistry of Drug Design and Drug Action

Rating: 3 out of 5 stars

3/5

()

Read preview

About this ebook

Standard medicinal chemistry courses and texts are organized by classes of drugs with an emphasis on descriptions of their biological and pharmacological effects. This book represents a new approach based on physical organic chemical principles and reaction mechanisms that allow the reader to extrapolate to many related classes of drug molecules. The Second Edition reflects the significant changes in the drug industry over the past decade, and includes chapter problems and other elements that make the book more useful for course instruction.
  • New edition includes new chapter problems and exercises to help students learn, plus extensive references and illustrations
  • Clearly presents an organic chemist's perspective of how drugs are designed and function, incorporating the extensive changes in the drug industry over the past ten years
  • Well-respected author has published over 200 articles, earned 21 patents, and invented a drug that is under consideration for commercialization
LanguageEnglish
Release dateDec 2, 2012
ISBN9780080513379
The Organic Chemistry of Drug Design and Drug Action
Author

Richard B. Silverman

Professor Richard B. Silverman received his B.S. degree in chemistry from The Pennsylvania State University in 1968 and his Ph.D. degree in organic chemistry from Harvard University in 1974 (with time off for a two-year military obligation from 1969-1971). After two years as a NIH postdoctoral fellow in the laboratory of the late Professor Robert Abeles in the Graduate Department of Biochemistry at Brandeis University, he joined the chemistry faculty at Northwestern University. In 1986, he became Professor of Chemistry and Professor of Biochemistry, Molecular Biology, and Cell Biology. In 2001, he became the Charles Deering McCormick Professor of Teaching Excellence for three years, and since 2004 he has been the John Evans Professor of Chemistry. His research can be summarized as investigations of the molecular mechanisms of action, rational design, and syntheses of potential medicinal agents acting on enzymes and receptors. His awards include DuPont Young Faculty Fellow (1976), Alfred P. Sloan Research Fellow (1981-1985), NIH Research Career Development Award (1982-1987), Fellow of the American Institute of Chemists (1985), Fellow of the American Association for the Advancement of Science (1990), Arthur C. Cope Senior Scholar Award of the American Chemical Society (2003), Alumni Fellow Award from Pennsylvania State University (2008), Medicinal Chemistry Hall of Fame of the American Chemical Society (2009), the Perkin Medal from the Society of Chemical Industry (2009), the Hall of Fame of Central High School of Philadelphia (2011), the E.B. Hershberg Award for Important Discoveries in Medicinally Active Substances from the American Chemical Society (2011), Fellow of the American Chemical Society (2011), Sato Memorial International Award of the Pharmaceutical Society of Japan (2012), Roland T. Lakey Award of Wayne State University (2013), BMS-Edward E. Smissman Award of the American Chemical Society (2013), the Centenary Prize of the Royal Society of Chemistry (2013), and the Excellence in Medicinal Chemistry Prize of the Israel Chemical Society (2014). Professor Silverman has published over 320 research and review articles, holds 49 domestic and foreign patents, and has written four books (The Organic Chemistry of Drug Design and Drug Action is translated into German and Chinese). He is the inventor of LyricaTM, a drug marketed by Pfizer for epilepsy, neuropathic pain, fibromyalgia, and spinal cord injury pain; currently, he has another CNS drug in clinical trials.

Related to The Organic Chemistry of Drug Design and Drug Action

Chemistry For You

View More

Reviews for The Organic Chemistry of Drug Design and Drug Action

Rating: 3 out of 5 stars
3/5

2 ratings0 reviews

What did you think?

Tap to rate

Review must be at least 10 words

    Book preview

    The Organic Chemistry of Drug Design and Drug Action - Richard B. Silverman

    _book_preview_excerpt.htmlսْg.*Ѳ9m ;H(ܙUɅKJL*K%E@ŒI뮯{#TO6zz%R̔Ɋ _w~WVEͿz0ѷ<ΒIt0˄_G,*ytedEq6*ɳw_ۿFݛIN>&%E\LAtXxH0˯^Ex4ee,CeRU\TKUX[f?zgeg:M,OJFA#x~7* ׆W9%xnIE62dn.պH拪mafDUUgIQV>p-->3شtXӤ\srA7 vdqó<}E{(J 8<2GMf Lai?d0zgG+̓I#/݈vyQ&&3='7a h*Iy݆s0Dw^|zs>OYUy~Sا}=q];>?g;iaxS9͸.*Ne6ucdI,}!|aȄCS?'P/\m u?tOf#p:?m<(M;V1ma}y~M{|/D$;4 n6q y]䅣Opp)~uPDs GTG*(WҸ,Mip^ĕcR-xϰ;<d>42+1U$tNMLYڟG{{ЌI鉻G{Q$Y9'{atkLէKT&3ӄN7Kt4699 kqNV/I'p1:7qjLGe1%QzDKV,Jg7z֩ɴZiI^>8Ie)p SyP26;twRZceD/@+VºߺJ2)ݮIm OFIc\EicYNx u@|63<3$hxrt%ݩ'QM5$_w׼%g;]L.Iln2>kҰC.j/ùz}u' _]tDKf^_Y"oUdx: قRӗɸ>gry2d^/bI+ʶΧsX'ڧ'&Q VAWi Htvlp؞VGx$vGgtKqj;\|HG87f$]>>>b}ױgwXD{QwDItEA6'#- 0y4lL1Y9ξ1q zVM$9EJiрu-BH`)ƃk,Ty%LM9)6p-\ȾjLwf6KB=t8 M wA|[y:6:+}ED$dA;eKwBDYȲ y_ɷ/ |\=1kcqֶ \lTΦ#+o1 ^<郀e:%(yP br|DrKHLG)SCD uF PrI'yz2 Ӟ)]}Yw?2PLa Y؝0}(ZCBtmCQP0KZ*pL0YuɆ q#LJ'AJ:+f\9)*%?'-5B)ۄSAj6qhi 6F:yn%=gEXnTNNM˚Yc|2DLśx Bj&~̖ApØp5ɋ$o⊮:Y8Tb苠# q@ұ`brh|aYŘdfB[)jyUhsNXK bU ap>q-Xwc'<ɋ%-o Ivp39!@b!-SHE;`TS='#ыā>VMjje3D׏ /N@R 'xuT~ZF8o~[$n(Hq@8&$"Zr:綨Bd2pCbgAW M$:"$LՎuYΨTqV3sA2.hVǖ)"aE%t1X6XKѐfYC޲Ef(),.Z=j=$*\ɭW n H𤋮:/tDԭp2U篊ZBfD#5(JFgKd_mKV32vdؼ_D'%"P ~Wɳ$$fc[2) NF  ֱAs6$OwZV?q^1"D3Xp+Y |q~}u/`&G!aQ&"Zhd.ɥv'3i_aL T*V$AȂ!..V=0}`!YmIKYhMzq˛{;C?8$>m( X,١?)7PN=M^fw%lW9zz=?=OA3iN^Rh5{eR:؊tk=,BC.QyRJB8LEciD ia1(2&!ĸH,Sk[M;48#b,,)$dXkhc z5iGQv%ίhjY3Z,@N^*>o^r&˰Ċ-1Atubx<n%_T%40 P6Ε0r>jOá[;:#3f:,Qf'jkXp~?;Y7B0ĥAtQs4:/N\ "eZsysً1 #ĵkt’ZUbC+^qF7}O+o:,qW U,@clld]åLad_O^aE7/GĺUxyO<^P@] /Ԙ"YE܈=:Hfa[ńVJ7+8T梷O2ߙBAhc. ɵA3þ%GY~ 2+2BifBIt9òvDN![5T|cbGR{ʸt^C.1w;d`q5X#sͳZex? !X@b.' ccЍ8`GJv^օ:&, B Ι_!YE.T#c^J' }OSxM6/N%4 \`\{0 4~Eis`gX{č$D|z f_P_t*$j6臟L8`{K|>~bOky67vXSB$1l"2N:i!^05.R] vu]5<=?<^! nzs@[^v?V"~qsf2{|;ٙ 2g|n kpI{͞uY0|Д'%I$8=&|$D!\Bo-묇s_*ZpҶvwMs01{{0EcC<qɆ, O6?O1=GH䝡>^1/}DU?#(zsy.yX`D+zףMLh$w2=̐X 7g"|"Ψ CGZfق [YQÇXLVM}\CKMbmtΦf|X?)vIFҽ@TԹ*VD3.&9h aN.+g%ji Eu;C;b$L"i _Z~A~a0 r8 '" 0 WQ} :;҆2T^~%fזK#yR)`P1k UvgAs)$A/e#Z;¼FN!Cң -$΋uYsIUzɶe0[;a<"n 8}B6°Kk0FIy^yLta!4(l6\ Fz tꨨ"Æ;0٘#o%5FZXnd3zK]K8R>&Xnp Ʉ\1}j:Ks!:S?(% =[_L®-ˌqCw4+ƈ ec}k$o}zL<5-=|@>]]"Hٴ)z<8Ǣؑ x  z $ML었 s/&a¾A'Љ8|ɍ`SQ3QT>Q.;ȎnrNh۶0CǩrYvU mn^= "(*-LZ!p]hвM}m1UYg:Bv%ꁔn$\..cˠ7z?JҘukE%'h"D>CL̘+B2WYFkp"L-!n<:.Oz z bDkL'[86W~[Iwn8Цs,;e=AQ{MMI}po߆{珅7mXc|X%bBQ"gдqPnjF(}^hJqZYt A(DzzRƢr!{i?Fv%tp8Jo-:lIy59vzY~0pDODDF÷}iM >qDQHT\Svt;fxO,ׄ$Y3qGG{p *$kO a_) 3ugY5㦟[<4"^uL_Ւ<[-=$z|,|oo pߩ3NN'__|uNdӺ`U\-PÄ$Op2h˜yrRJ{)ɫʫ%"gQ/@dq(D'8>cѽϳ-eDy aDS7M6$K.'F$UA`ȶ*8Qp2`OK&+0^I|Ejp;<Ȯ=LYq$P(*,Wd(b7|z $E!|yzh#&aY;#QRPcj1\q]%cT}a޶Xf;QZnc+`g+)@@bt8IFys ӋH iiO^0zI"POh;JO!85Jg@d{ƶ8qd<ɬERɠtg8 Vcoˤkɢd1w{.AyA&O@Qw)X\$$Vj T,4t.9#Xp9yQjk"eh0q#X%FKbcf'd=.(BZ-/j𩆘o''H4k6MOkgI4EhKͲ ! 鬡eH5& ̆Y۳Lg }sNOF{[4 ɽdKF}lu5$3X2:~wޝ QM ,1!酅VUspL ? ƤtRK7EgdQ&#KIw^)$2J|Vy0*R͈\㑏OyAők?z^F:g%uz@JE#KU܄K}\Ye>&s{6?qDN'e :cOCƍ $PK=br"J`a(M0|y6F%f%qMuR |:==*pVqgvJx!f%'N\:<=gh2d|S[53+vX8*gbV<Zۑ@5Qr$ v.h!6#@Y Sh^Þq8|P+\/yӭEx/B}7\QRY5[(19 gDn쩩V,y$ MNQƑ Wx́ǼBʉ,/晵!Y; 5{шD' DOE둫vclG'h$*46.Wϱ芿 -wmWEt^dy8l﹢$W3 F<Jb}m3,HH۳pK9ll$ R*L?g3s0s8++"lnfn#[Am#Y+6MY\׶tC{ो)ְcꕗ )|t a8yU>\=j[g©l'wӊ8eyV'G}l+}ׁ6_m&Qц+_3_B[O"T1}i6Oz 'gHp!˜o}MXw|B3) k(?c_Z9V0=] CvE)e\2؜5|I?gϹ7k4~!3Ytj:܏݌m1alt|+Qޤ q"X>9z]M Y߶RwH0&M|By3Iw,ݰ)sž3dc`͘76ujZ9,2/c/b4Kˈ>+UcwNEu`+^c!NOH!ʼn?/3hw~F LǏk F*Gy6Vo ' ?Cp=ܒZ//.xq{0:U/lћzp:_8ɾE.iOKN@?MB8,%]"}Zr!u +W}2BOwm!"#= _L͆9r¢39\HB_ieeq?Y,ٌƒu.8j-d[s s|,c7Vd(EI8Mx PX¸E}ۗ9}qO2sg<Ӑt 0ɺij]}[ ~T?| 8>|APZ/UBǓ]Ŝ3n7&)p͵9cznಶK3/#6_efTgS} VDy«|V3ԟL VɅcM=}ϙ%_kl6H4~Ni$ds{,OӣS78'R'p;]&tYب*D?|ƒ48e]ݕxxlҨn=|H~%30r|rx-\K%yVlZ՞bL4?CA/cPGԽ4 nJJJ V%2m% OpUpZǔË3^_> N&prVp/kW<,ߎQ5lܶW{ޠS7A'wRFYiwl"EO[,T.l;ν$52 ]k} 7.;9ԍu2m []C|/qw6gG,ga+ݡc<@؉x$ۑhC"\Bh ڢXJʛd8Oܼ%yi69~moMU^}b#]NLZnTؘ=ܳ_.lĐS䞽=%{^&dgx{rny7ڥ zR"/oJtv7f#棫+K=;_z5Oz&<:њΑ0Ź"/E @5%@jIsR߅/҈@r/i^dz1~՞jX)(qQa-y^,^xIYପOH{I-bwl cx 9\#,ՠ,-pY\`ic!QmRCΉ *|2. 5%qEWYAg2)L͋{r=b]tʼb(1O\g/UePDiz>]%-| aw+~uX(HBfL]j?[՟%n "fxý>k}c6Mu#?K( 0 xӎBPcę(,0M#YۜQ~&!hOmMO:=c2'E4E("Ng=SY *Ge;Ӽ)ba6JGli5 8ӝNA,Ĥusbn$ ƾ?JpYk8Ȃbhq9+eIl6c%:CsOQ4yQZf#FnĦa䍜_QS{+@,3Lj45YnQu!NQx b*[ۓk4t2H|W+ZSP@Ҏz8$HغK/ ي>#]$cP9kT/'QF m9\s5lZ"烔qrCZhDsP^_[zbn  Qd{*3 _6t ΙY4(y~Dۂ[%BU׮$R._/'Ә z"љUa>.qjs&С y'KTjAjmkY-so)qx,Z8ƒn]J͹MvagoF]O V\1bp]%펕=JG`dfB:/dؐixj"I\)~ZK>i9;4靈ul.WijSKq \ZÛޕUXU%9NoWpk-_l4Li vpk7̹ )7x]$7mw={:: ƟEa" \7AKH\Zurl4uq-#|vF?"Iv&^B#haK=On~[m6h.}PmkI}-ɷ},fn{\4v^PZ) xF"rWȊP.fo z^pYΉJd]-g w0:/jA8+X' >VxN$h#s%rJYpظ>C(UU*!b\!RG&u? yAc%&CJ(fo?uOzt3- m4ݴvNMl/txVF+"ӲWg; W ՞qSr ЋT8p& .JL4W",YPh+wU5K{|;%AoP W!r@F~^B%ST.HVTzl6mM.kk>/IɄ ht⩖J$FafE2F'٤ 'F=PĪ*pIBb+$XcVQ C& 󣰂=k&%, JRi)͇*Nx^zKgRWHsYYR]cnUD[m9S [qj6uvz^'F.\4$:JWjǝN.ʮ1"#o'T%[wzaDem{J:ŷVKfq~.GbBBX2”ٲXI$0 Ϲ\?`KFBo,g6S&=9:`y˝S/bۘHRY\BV*7 #i)%oo3MΤ5x,QbOYҙ_=,[Wq: K,caYa:BלN*Ks +B zv, H,}R6p^!K49*G,W\ga uXC9=Jvz 2blqae^n ߺn4w*R d)δ wP8u2ͤu)(JWnL;+ kF=k|tFe KJ2ob(p遏>Cݏ p88\ FD@J:bCØvŕ ;cO* AfU(`C|ZѶm[Hc\hC -(<[Ҹ󏹴;-F֔R;m~T@'4oO\ș(9jc.\GNZWАehmP0YX[x"@ k'V+;!"Uc}0JqYXĵNU~!-dٶ۵m7B#Ocُ%pb]`kJQ1HԶk(~ZK&*dR: ϸlIb1=(YJZjf.=ΉK3ij5":Hw t+5&'^E{%an/"'6ߵT/V3Zi<ܫط 2!N>'u]_货ַjPTY\TW %K_C vrxeDsgO>?y6Xe/hdZ-D1 uyFj7Ny$";M_~_5-n:ww.yOj\jʸ[w]&1Ȍ"Key=>$` bjI%VĶO8'`e/.]>t̚K-]ktwx_\/9I~Oο{~{ǻ]7(Lqp/*|7aR֗:pϸȤw렲@}3 eul'%14.yE ݌gK0z͓2|Xu0Q:)pCܙYD ?.Fk=!!DKGdf :IP ܞHJ.&qMiI=mb%jq$b@frjiQ_ _ӵ1Dji#yX&`y@+ZCӈaI֍A2g?|26uGT]@S@|\B+~g IZ[so/Rw[ lh\%HuXgܔi7Tnf}Kd F^`G!i$1( ۜt3ؑJD[MA ~BLb'   g{Bͨ8-eXrNW3=uڰNɎиH>MJōE 5%b&ͱH`@KHXhWnVژ7B [C M`} & 'S"G{ɒD9p11hn>Bь/~"Eה1܎Dkْ!1싅MX 15uEknwH:Bi4:&uZr5xw)jh ,H3%GiB+Ԋ|s"'.,"]x3 cmffzHeq79Fƙ|eT84-jG/bi[.$p,}4q.]٭\-v^F;|+"gVkqP77ԾIӓS~1Ian&'NL.[R<?r* *g`âD`Az.Ep|I!REwxZLqoNJZ(Q"%kja<M'>Ъ*sK/g~4 Lc@s5Ԕer.̫q4܄NΈC:c$MXE ̠6!ej rt)$s['1mrUDz &X]#[ D v4ҮFLT9CD%vL]+rEVjB2COM-ِ:hVrJ΢#Ocqde]H׹%3FyLpr/-W@1uQFfpzVn <>\G($ѐkfK׍6 6_jQoi!՗թ,98ў> DQA Ēj_!mxƭTP_']6@qT:{}';zᱠzKFѪni쑪3zܤ\7-qkSz\@͆PAgAL-[6]DFX9p\#p I$IDSx׼nS_ vؒ6N8M{#q9FwS[Px3v+pȭE135){oI+[R][e9!#3Ȃe#"d\KO}@#Hdr:|bk*I+7~՚lJ4j`,H G͜mW·|h;.\Beq6;dTIt.vڊ$NۙR3+o*5bJC3i%{uJZDќ^wSW4'$Tk8l!;zwnhZ-d"Pwpn'k.M%V(mz_XLp 7c66<| b(G,Ah_=5ENJ }:kp 2}X 2t`QD\CTD)Tm6h+vaɥf)4kX }V `k5J:VoRӭ\J4݉t3K.q|O  "I{km˦?fK/B): Fۋ~4;SBc4֞U@gQ M13zh9rb{&wDtq")#Idb]-~]BЧ `'1&Ee)6R0z^h85oM>^$\( M{6g@w@ @jt ~.,(Ic-\Q[ X 34(dSrn;nM7b\KU_:%m V6.!@seV^Tk=dFhm=ԑ&6a$Q.D gbWyMpXI; n|y]dͽ;xpe@()"(@"^rYHr4f\XqK 08TR :LÅ @7+%@hK&2N|GcwaX3&Ѭ\h #El9}+u?}h-R /<5@o7pDnƫ|2j;ҲśhQäɚ#&S^h ]@" +JUAYthUʥa4"Z e,~HDҠvYO,Q *89M23IFA}JfKz*HJj3 k5V^B0A% t º$q2g@,WyՓ7=BqL9_{i-G÷rO!<2Zmͺ6Ac(ɃY]r]-vƉ/^eG*Y8p929wDӀd^M%tqkzov=8 2P j9( %klDDndH#ZCa ;;욦/>8 ilF.a,wZ]=W5o!ށ=7>.svߛrjrYb}!BI`B8og+|]\KlvscNFE Y|`Gg`  1^J (M ^"BBo%dG.u9IxT^jR4Mum!hcjdxd ԎvnFc@[Uyt^e!pVң?@U.ZPߺ-ei=@F:; Y0ܺ]+xA/gُm;7K7Jix-r"pRz7آvk#Gn -\-hvrY OArDXG|d<w‘F@UV:F$%CWS0P} {1~^RfpVq&|ɧ뾿tqißA ddǦ( q 2櫅8S_qʲzbn;6&DRŤ_7L?=<;^Cp(iml;ky3 Pns .bϚk1ە! ]}8+ 4wd#L{U7$(d:_{Y(SڐZ Dbx+&yŰ IӸK礿$?KM@0X8B 3JɕTrʹ5&Wt/aj&3$,pOg .a"$Q~`v05 3MEiSC9F&a5E'BS5=D[Җc la$-:ؘT")|_ *5p>Onx m[FߢS9fMf(݉ZbxEW2 `i%x׍ `P@6چ?8O][G[F-A,ٺJȜ#Nר/zL)}EZW_ffm!Noa O5.aijfqfK]Y]bZ.BSC`X}\?r1W_bQ$'P) kTeBtMठ}5܂ 2%1qRD=`aedʅU53|Ԧ6 v2 [ Bt Mp튦q6O5#\* -,TXKV=  `e5b߾1(G)'$CRE(=*5xW}V6XMmճ!) 0LkCtU57;k&[%? `_Z=:}bhd\'p_<%h29|0 L wIsy7Ub-G]mrAm~0ƾB.o \#r -cUźԥttz\,:.DoIa5vOKh[bb7DqH415Z)C$cK K\9eY[5I$Hzh9y^냓<_Qjk{vuv2lT,Z3wu|t¼:ewetqWRNG^Q@#h/YUl2xFj*I] ?de_-}ȭP7#22'vNLOqtU@H0I m;PJ2vb_kI<- :5,Azm8s M3!cLНKS>@"9 7gS4Ys VklڦrL1K85]bgH' 9*wgd4쵑14F(7@`KZDO߫?QޜAz[&Ҕmqw^tb;)7{0mO8Goק/|r?zI+܍B@% CRhz(e~!X%b.J$tL m4NkB=RGWcH%N]$MgĝUR_tB գ0pۉb[خser!b$Uہ5XӾ _Y"mxqs6./+oJםSwtzw8i AjkV't)k-r4'GGfsRb35 Qj\%3xmU{ѫow}4lbk1S\kcBT$p5Ɔ^V $_h"FCĤ(tXBBiy*h:ۈ]nsi( 0Ŷyݩ5V0(t\u%A YވԺPf,#f@PwXP7 Jz7 KMYyB)Ҡϴ"+QB@EY4cnYrqLF\V%'(]FGo6*$)`$:]; :Zܻ= gȫXK'h+s`*I(R'|QF-n"I&:stB_ 'RLcKSpe>.8tlj|?7o*7.3>tuvG=L,- l~ ߸M;+0_ +|,<!LZU"AH`i} 35+7K%_*>vGJP'fa JVz`B1[?K廓S1k-jDd6I=x664\UmD/4iޑHSfi= d%biHCboC}nΙCu:YEBMơ)J/MlX7c`G 7>uOϾ7(KIyWrfq<`?ƹ]+egO٣vb>>Χ WewIE8%L-g8 9hcz1ռb=/!MTEòV5vsm'6*:q#P\^yKiش[]D;Ц8$ 1p l5`L\!"z}vFCg';$\BY%34^J&^q]IĝΗ}sFNyFF)I܎kAg>*,Y[ovԌ0Aꢜ[4ZCrP F8ڝbkխ7;g{/;[ȘPw [4wKoMʹqr>:.TD3B2^ L+ ԍ&vJ94C a y:'((8i%6>Mj.#nͪ._31Ź_Y*ޠ a9MS4i|VETBg~X0xlEm@J:(kvDow:eɊv]F~4fl?fx!TCKhQ}[;睁{;k+q,H'G'eQ/w/ g x{kn\5CF4$ "*g/ \T/E CZ4#QU2J\8p&ZWy5
    Enjoying the preview?
    Page 1 of 1